Health Conditions A-Z Health & Wellness Nutrition Fitness Health News Ayurveda Videos Medicine A-Z Parenting Login to get the latest articles, videos, gallery, and a lot more or continue with Email Google Facebook To get Registered Signup now Credit: iStock/Wegovy Rachel V Thomas Updated Jul 20, 2026 | 10:24 AM IST Summary Novo Nordisk said that Wegovy is the first and only GLP-1 receptor agonist (GLP-1 RA) approved globally and in India for the treatment of noncirrhotic MASH in adults with moderate to advanced liver fibrosis, alongside a reduced-calorie diet and increased physical activity
Additionally, semaglutide is approved for chronic weight management in adults with obesity or overweight individuals with conditions like high blood pressure or high cholesterol
Reducing Appetite: By acting on areas of the brain that regulate appetite, GLP-1 agonists promote feelings of fullness (satiety), leading to reduced food intake
It is known to promote collagen synthesis and act as a strong antioxidant
Not all plans require it, but some do At your consultation: The physician will document your medical history, diagnoses, and the recommended treatment plan
